Abrir o app
Top 100 rádiosPodcastsDesporto ao vivoPerto de tiGéneros musicaisRádios por tema
PodcastsCiênciaBiotechTV - News
Ouve este podcast gratuitamente na aplicação:
BiotechTV - News
radio.pt
Sleeptimer
Guardar rádio
Descarrega gratuitamente na App Store

BiotechTV - News

BiotechTV
CiênciaCiências da Vida
BiotechTV - News
Último episódio

393 episódios

  • BiotechTV - News

    Barclays Miami: MannKind CEO Michael Castagna shares an update on the company, including a recent $360M acquisition, and two regulatory reviews at FDA that have decision dates over the coming months

    11/03/2026 | 14min
    He describes learnings from Afrezza's commercialization, why the company acquired scPharmaceuticals, an update on their partnership with United Therapeutics in PAH, and a key IPF asset that is in the pipeline.
  • BiotechTV - News

    Barclays Miami: Barclays' Senior Biotech Analyst Etzer Darout shares his take on biotech and discusses companies he covers that have been in the news

    11/03/2026 | 14min
    He comments on Abivax, Corvus, Iovance, Legend, Terns, and more.
  • BiotechTV - News

    Barclays Miami: Zealand Pharma CEO Adam Steensberg makes the case for last week's amylin data

    11/03/2026 | 12min
    He argues that investors are too focused on each percentage of weight loss and not focused enough on the tolerability of new options. He discusses the timeline for the phase 3 that will likely start later this year, and how it might look different than the phase 2 study that just read out.
  • BiotechTV - News

    Barclays Miami: Barclays' Head of Healthcare M&A shares his take on the current environment of dealmaking

    11/03/2026 | 5min
    Maneet Singh says that pharma companies need to keep buying, and have the financial wherewithal to do it. He also gives thoughts on which areas within biotech could attract the most interest.
  • BiotechTV - News

    Reunion Neuroscience recently received Breakthrough Therapy Designation from FDA for its psychedelic based treatment for postpartum depression (PPD)

    11/03/2026 | 11min
    CEO Greg Mayes describes the science behind luvesilocin, which is a prodrug of 4-OH-DiPT, a psilocybin-like compound, and discusses the company's plans for a phase 3 study. Plus, comments on two other indications the company is pursuing.

Mais podcasts de Ciência

Podcasts em tendência em Ciência

Sobre BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.
Sítio Web de podcast
CiênciaCiências da Vida

Ouve BiotechTV - News, E o Resto é... Ciência e muitos outros podcasts de todo o mundo com a aplicação radio.pt

Obtenha a aplicação gratuita radio.pt

  • Guardar rádios e podcasts favoritos
  • Transmissão via Wi-Fi ou Bluetooth
  • Carplay & Android Audo compatìvel
  • E ainda mais funções
Abrir o app

BiotechTV - News: Podcast do grupo

Empresa
Informação legal
Assistência
Aplicações
Social
Radio Portugal
v8.7.2 | © 2007-2026 radio.de GmbH
Generated: 3/12/2026 - 12:04:40 PM
Uma empresa deMADSACK